Cargando…

Corrigendum: The Experience Elicited by Hallucinogens Presents the Highest Similarity to Dreaming within a Large Database of Psychoactive Substance Reports

Detalles Bibliográficos
Autores principales:	Sanz, Camila, Zamberlan, Federico, Erowid, Earth, Erowid, Fire, Tagliazucchi, Enzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5905397/ https://www.ncbi.nlm.nih.gov/pubmed/29676402 http://dx.doi.org/10.3389/fnins.2018.00229

Ejemplares similares

The Experience Elicited by Hallucinogens Presents the Highest Similarity to Dreaming within a Large Database of Psychoactive Substance Reports
por: Sanz, Camila, et al.
Publicado: (2018)

The Varieties of the Psychedelic Experience: A Preliminary Study of the Association Between the Reported Subjective Effects and the Binding Affinity Profiles of Substituted Phenethylamines and Tryptamines
por: Zamberlan, Federico, et al.
Publicado: (2018)

Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey
por: Garcia-Romeu, Albert, et al.
Publicado: (2020)

25C-NBOMe: Preliminary Data on Pharmacology, Psychoactive Effects, and Toxicity of a New Potent and Dangerous Hallucinogenic Drug
por: Bersani, Francesco Saverio, et al.
Publicado: (2014)

Is Shame Hallucinogenic?
por: McCarthy-Jones, Simon
Publicado: (2017)

Associations between individual hallucinogens and hallucinogen misuse among U.S. Adults who recently initiated hallucinogen use
por: Jones, Grant, et al.
Publicado: (2023)

Optimization through a Box–Behnken Experimental Design of the Microwave-Assisted Extraction of the Psychoactive Compounds in Hallucinogenic Fungi (Psylocibe cubensis)
por: Polo-Castellano, Curro, et al.
Publicado: (2022)

Language as a Window Into the Altered State of Consciousness Elicited by Psychedelic Drugs
por: Tagliazucchi, Enzo
Publicado: (2022)

In Silico Investigations into the Selectivity of Psychoactive and New Psychoactive Substances in Monoamine Transporters
por: Botha, Michelle J., et al.
Publicado: (2022)

ANALYTICALLY CONFIRMED PRESENCE OF PSYCHOACTIVE SUBSTANCES, ESPECIALLY NEW PSYCHOACTIVE SUBSTANCES IN A GROUP OF PATIENTS HOSPITALIZED WITH MENTAL AND BEHAVIOURAL DISORDERS DUE TO THE USE OF PSYCHOACTIVE SUBSTANCES DIAGNOSIS
por: Engelgardt, Piotr, et al.
Publicado: (2022)

Poisonous & hallucinogenic mushrooms
por: Haard, Richard
Publicado: (1980)

Novel Psychoactive Substances and Behavioral Addictions
por: Martinotti, Giovanni, et al.
Publicado: (2014)

Editorial: Pharmacology of new psychoactive substances
por: Lutfy, K., et al.
Publicado: (2023)

Corrigendum: Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification Treatment
por: Specka, Michael, et al.
Publicado: (2021)

Novel Psychoactive Substances: The Razor’s Edge between Therapeutical Potential and Psychoactive Recreational Misuse
por: Correia, Beatriz, et al.
Publicado: (2022)

Brain mechanisms of hallucinogens and entactogens
por: Vollenweider, Franz X.
Publicado: (2001)

Hallucinations and Hallucinogens: Psychopathology or Wisdom?
por: Bouso, José Carlos, et al.
Publicado: (2023)

Psychoactive substances and the political ecology of mental distress
por: Aggarwal, Sunil K, et al.
Publicado: (2012)

PSYCHOACTIVE SUBSTANCE USE AMONG MEDICAL STUDENTS
por: Ali, R.V. Zulfikar, et al.
Publicado: (1994)

Banning Psychoactive Substances: A Slippery Slope
Publicado: (2015)

Priapism associated with novel psychoactive substance abuse
por: Jones, Patrick, et al.
Publicado: (2015)

An Expanding World of Novel Psychoactive Substances: Opioids
por: Zawilska, Jolanta B.
Publicado: (2017)

Experimentation with psychoactive substances by public school students
por: de Andrade, Maria Eliane, et al.
Publicado: (2017)

New Psychoactive Substances: A Matter of Time
por: Pantano, Flaminia, et al.
Publicado: (2019)

New psychoactive substances: a review and updates
por: Shafi, Abu, et al.
Publicado: (2020)

Psychoactive Substances Taken with Mephedrone and HCV Infection
por: Ordak, Michal, et al.
Publicado: (2021)

Molecular Insights on New Psychoactive Substances (NPSs)
por: Busardò, Francesco Paolo, et al.
Publicado: (2022)

An Update on Psychoactive Substances: Pharmacology and Toxicology Issues
por: Chiappini, Stefania, et al.
Publicado: (2023)

Genotoxicity Evaluation of The Novel Psychoactive Substance MTTA
por: Lenzi, Monia, et al.
Publicado: (2023)

Deaths from novel psychoactive substances in England, Wales and Northern Ireland: Evaluating the impact of the UK psychoactive substances act 2016
por: Deen, Adrian A, et al.
Publicado: (2021)

Characterization of new psychoactive substances by integrating benchtop NMR to multi‐technique databases
por: Castaing‐Cordier, Thomas, et al.
Publicado: (2022)

Baseline Power of Theta Oscillations Predicts Mystical-Type Experiences Induced by DMT in a Natural Setting
por: Tagliazucchi, Enzo, et al.
Publicado: (2021)

A STUDY OF COMORBIDITY IN PSYCHOACTIVE SUBSTANCE DEPENDENCE PATIENTS
por: Kisore, Pankaj, et al.
Publicado: (1994)

Prevalence of psychoactive substance use among youth in Rwanda
por: Kanyoni, Maurice, et al.
Publicado: (2015)

Effect of Different Psychoactive Substances on Serum Biochemical Parameters
por: Sanli, Dilek Beker, et al.
Publicado: (2015)

Novel psychoactive substances: What educators need to know
por: Patterson, ZR, et al.
Publicado: (2016)

Sex and Gender Differences in the Effects of Novel Psychoactive Substances
por: Fattore, Liana, et al.
Publicado: (2020)

Sudanese Medical Students’ Perceptions of Psychoactive Substance Use
por: Ibn Auf, Anas, et al.
Publicado: (2020)

Stress and psychoactive substance use among university professors
por: Vieira, Alcivan Nunes, et al.
Publicado: (2021)

An Update on the Implications of New Psychoactive Substances in Public Health
por: Simão, Ana Y., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vacrnv598jhn95qeu5edlpbval